51 – 60 of 259
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial
Persson, Astrid E LU
; Kjellén, Elisabeth
LU
; Garmo, Hans
; Adrian, Gabriel
LU
; Stattin, Pär
; Widmark, Anders
; Nilsson, Per
LU
and Gunnlaugsson, Adalsteinn
LU
(2024)
ESTRO 2024
In Radiotherapy and Oncology
194(Suppl 1).
p.2287-2291
- Contribution to journal › Published meeting abstract
-
Mark
Cost-effectiveness analysis of (accelerated) pre-operative versus (conventional) post-operative radiotherapy for patients with oral cavity cancer in Sweden
Silfverschiöld, Maria LU
; Carlwig, Kristin
LU
; Jarl, Johan
LU
; Greiff, Lennart
LU
; Nilsson, Per
LU
; Wennerberg, Johan
LU
; Zackrisson, Björn
; Östensson, Ellinor
and Sjövall, Johanna
LU
(2024)
In European Journal of Health Economics
25(1).
p.177-185
- Contribution to journal › Article
-
Mark
Behandling av icke spridd prostatacancer – individuellt val
- Contribution to journal › Article
-
Mark
Hematological and renal toxicity in mice after three cycles of high activity [177Lu]Lu-PSMA-617 with or without human α1-microglobulin
Kristiansson, Amanda LU ; Vilhelmsson Timmermand, Oskar LU
; Altai, Mohamed
LU
; Strand, Sven-Erik
LU
; Åkerström, Bo
LU
and Örbom, Anders
LU
(2024)
In Scientific Reports
14(1).
- Contribution to journal › Article
-
Mark
In vivo MRI and PET imaging in a translational ILD mouse model expressing non-resolving fibrosis and bronchiectasis-like pathology after repeated systemic exposure to bleomycin
Mahmutovic Persson, Irma LU ; Fransén Petterson, Nina ; Liu, Jian LU ; in ‘t Zandt, René LU
; Carvalho, Carla
; Örbom, Anders
LU
; Olsson, Lars E.
LU
and von Wachenfeldt, Karin
(2024)
In Frontiers in Medicine
11.
- Contribution to journal › Article
-
Mark
Morbiditet från urinvägar och tarm enligt registerdata efter ultrahypofraktionerad strålbehandling för lokaliserad prostatacancer vid 10 år i HYPO-RT-PC-studien
Persson, Astrid E LU
; Kjellén, Elisabeth
LU
; Garmo, Hans
; Adrian, Gabriel
LU
; Stattin, Pär
; Widmark, Anders
; Nilsson, Per
LU
and Gunnlaugsson, Adalsteinn
LU
(2024)
Onkologidagarna 2024
- Contribution to conference › Poster
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
Ascic, Ervin LU
; Åkerström, Fritiof
LU
; Sreekumar Nair, Malavika
LU
; Rosa, André
LU
; Kurochkin, Ilia
LU
; Zimmermannova, Olga
LU
; Catena, Xavier
LU
; Rotankova, Nadezhda
; Veser, Charlotte
and Rudnik, Michal
, et al.
(2024)
In Science (New York, N.Y.)
386(6719).
- Contribution to journal › Article
-
Mark
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE
Warfvinge, Carl Fredrik LU ; Gustafsson, Johan LU
; Roth, Daniel
LU
; Tennvall, Jan
LU
; Svensson, Johanna
; Bernhardt, Peter
; Åkesson, Anna
; Wieslander, Elinore
LU
; Sundlöv, Anna
LU
and Sjögreen Gleisner, Katarina
LU
(2024)
In Journal of Nuclear Medicine
65(7).
p.1070-1075
- Contribution to journal › Article
- 2023
-
Mark
Co-injection of anti-HER2 antibody Trastuzumab does not increase efficacy of [177Lu]Lu-PSMA-617 therapy in an animal model of prostate cancer
Abouzayed, Ayman ; Zedan, Wahed LU ; Altai, Mohamed LU ; Strand, Joanna LU and Örbom, Anders LU
(2023)
In American journal of nuclear medicine and molecular imaging
13(3).
p.107-117
- Contribution to journal › Article
-
Mark
Targeted spatial proteomic analysis of CD8+ T- and myeloid cells in tonsillar cancer
Altunbulakli, Can LU
; Jimenez, David G.
LU
; Askmyr, David
LU
; Sobti, Aastha
LU
; Swoboda, Sabine
LU
; Greiff, Lennart
LU
and Lindstedt, Malin
LU
(2023)
In Frontiers in Oncology
13.
- Contribution to journal › Article